Here are five points:
1. The institutional investor owned 6,464 shares of AmSurg’s stock, and it bought another 143 shares.
2. The investor’s holdings in AmSurg were worth $491,000 at the end of the most recent reporting period.
3. AmSurg shares have a 12-month low of $53.55 and a 12-month high of $87.42.
4. The stock’s 50-day moving average price is $74.39, and its 200-day moving average price is $77.71.
5. The firm has a market capitalization of $3.49 billion.
More articles on ASC issues:
Americans don’t think ACA is top issue in 2016 election — 5 things to know
7 things for ASC leaders to know for Monday — Feb. 1, 2016
Bernie Sanders is in good health, physician reports: 5 things to know
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
